Mark A. Sirgo,Pharm.D

2013

In 2013, Mark A. Sirgo,Pharm.D earned a total compensation of $2.5M as President, Chief Executive Officer and Director at BioDelivery Sciences International, a 221% increase compared to previous year.

Compensation breakdown

Bonus$276,552
Salary$462,734
Stock Awards$1,760,708
Other$23,849
Total$2,523,843

SirgoPharmD received $1.8M in stock awards, accounting for 70% of the total pay in 2013.

SirgoPharmD also received $276.6K in bonus, $462.7K in salary and $23.8K in other compensation.

Rankings

In 2013, Mark A. Sirgo,Pharm.D's compensation ranked 3,086th out of 12,286 executives tracked by ExecPay. In other words, SirgoPharmD earned more than 74.9% of executives.

ClassificationRankingPercentile
All
3,086
out of 12,286
75th
Division
Manufacturing
1,039
out of 4,612
78th
Major group
Chemicals And Allied Products
272
out of 1,462
81st
Industry group
Drugs
186
out of 1,156
84th
Industry
Pharmaceutical Preparations
154
out of 890
83rd
Source: SEC filing on June 5, 2015.

SirgoPharmD's colleagues

We found five more compensation records of executives who worked with Mark A. Sirgo,Pharm.D at BioDelivery Sciences International in 2013.

2013

Mark Sirgo

BioDelivery Sciences International

Chief Executive Officer

2013

Andrew Finn

BioDelivery Sciences International

Executive VP of Product Development

2013

Andrew FinnPharmD

BioDelivery Sciences International

Executive VP of Product Development

2013

Ernest De Paolantonio

BioDelivery Sciences International

Chief Financial Officer

2013

Ernest De PaolantonioCPA

BioDelivery Sciences International

Chief Financial Officer

You may also like